PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33099927-6	2020	Inhibition of the MAPK pathway by EGFR inhibitors ositinib or MEK 1 and 2 inhibitors selumetinib prevented the up-regulation of CD274 mRNA and PD-L1 proteins and membranes induced by EGF and IFN-gamma.	AZD 6244	85-96	interferon gamma	Homo sapiens	191-200	
30972766-8	2019	Inhibition of the MAPK pathway, using EGFR inhibitors cetuximab and erlotinib or the MEK 1 and 2 inhibitor selumetinib, prevented EGF- and IFNgamma-induced CD274 mRNA and PD-L1 protein and membrane upregulation, but had no effect on IFNgamma-induced MHC-I upregulation.	AZD 6244	107-118	interferon gamma	Homo sapiens	139-147	
24200969-9	2014	We experimentally showed that TNFalpha, EGFR, IFNalpha, and IFNgamma pathway activities were also upregulated in melanoma cell A375 compared with its sub-line DRO, while DRO was much more sensitive to AZD6244 than A375.	AZD 6244	201-208	interferon gamma	Homo sapiens	60-68